We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

December 9, 2009

Teva Pharmaceuticals USA, Inc. et al v. Sandoz Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. July 16, 2013

    Sandoz, Mylan Slip Teva Patent Suits Over MS Drug Research

    Mylan Pharmaceuticals Inc. and Sandoz Inc. on Tuesday escaped almost identical infringement suits by Teva Pharmaceuticals Ltd. after they agreed to stop using its patented technology in seeking U.S. Food and Drug Administration approval for generic versions of Teva's multiple sclerosis drug Copaxone.

2 other articles on this case. View all »


To view the parties, register now.